The largest database of trusted experimental protocols

Glomax navigator luminometer

Manufactured by Promega
Sourced in United Kingdom, United States

The GloMax Navigator luminometer is a compact, easy-to-use instrument designed for measuring luminescence-based assays. It provides a reliable and consistent method for quantifying luminescent signals, making it a versatile tool for a range of applications in life science research and development.

Automatically generated - may contain errors

28 protocols using glomax navigator luminometer

1

APP Amyloidogenic Processing Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amyloidogenic processing of APP was monitored in HEK293 cells essentially as described using an APP-GAL4 reporter assay that drives GAL4 upstream activator sequence (GAL4-UAS)-dependent expression of firefly luciferase [22 (link)]. Briefly, APP fused in frame at its C-terminus to GAL4 was co-transfected into HEK293 cells with a GAL4-UAS-firely luciferase reporter gene (pFR-Luc), Renilla transfection efficiency control plasmid (pRL-CMV) and either KLC1wt or KLC1S460D. BACE1, α-secretase and γ-secretase cleavage of APP releases the APP intracellular domain fused to GAL4 which translocates to the nucleus to regulate expression of firefly luciferase. Transfection efficiency normalised firefly luciferase signals thus provide a readout for amyloidogenic processing of APP. Cells were transfected in 24 well plates at 70–80% confluence with 0.25 μg each of APP-GAL4, pFR-Luc and either KLC1wt or KLC1S460D, along with 0.025 μg of pRL-CMV Renilla control plasmid. Cells were transfected as described above (see Cell culture and transfection). Luciferase signals were developed 24 h later using a Dual-Glo Luciferase assay kit (Promega) according to the manufacturer’s instructions and quantified using a Promega GloMax Navigator luminometer. Full details of the assay including design and construction of plasmids have been described previously [22 (link)].
+ Open protocol
+ Expand
2

Phage-based Bacterial Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial log-phase cultures were diluted in culture medium/SHU or filtered human urine to an OD600 of 0.01 (~107 CFU/ml) and infected with reporter phages at an MOI of 0.1 (E. coli and Klebsiella) or at an MOI of 2 (Enterococcus). Sterile medium spiked with reporter phages alone served as background controls. For E2, E4, K1, and K4, the infection reactions were incubated at 37 °C with shaking (180 rpm) for a total duration of 3 h. For EfS3 and EfS7, the reactions were incubated at 30 °C without shaking for 4 h. For time-course assays, an aliquot of each mixture was taken every 20 min for luminescence measurement in NuncTM F96 MicroWellTM plates (Thermo Fisher) and using a GloMax® navigator luminometer (Promega) with 5 s integration and 2 s delay. Based on manufacturer’s instructions, the buffer-reconstituted NLuc substrate (Nano-Glo Luciferase Assay System; Promega) was added to the infection mixtures at 1:1 ratio (40 µL total). Relative light units (RLUs) were divided by the RLU from phage-only controls and quantified as fold change RLU. All strains used for specificity assays are listed in Table S2.
+ Open protocol
+ Expand
3

Pseudotyped HIV-1 Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmas were five-fold serially diluted and then incubated with pseudotyped HIV-1 reporter virus for 1 h at 37 °C. The antibody/pseudotype virus mixture was then added to HT1080/ACE2.cl14 cells. After 48 h, cells were washed with PBS, lysed with Luciferase Cell Culture Lysis reagent (Promega) and Nanoluc Luciferase activity in lysates was measured using the Nano-Glo Luciferase Assay System (Promega) and a Glomax Navigator luminometer (Promega). The relative luminescence units were normalized to those derived from cells infected with the pseudotyped virus in the absence of plasma. The half-maximal neutralizing titer (NT50) was determined using four-parameter nonlinear regression (least squares regression method without weighting) (GraphPad Prism).
+ Open protocol
+ Expand
4

Cell Viability Dose-Response Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated as indicated for 96 hours prior to assessment of cell viability using CellTiter-Glo 2.0 (Promega) per manufacturers’ protocol. Luminescence was measured for 10 seconds using a Promega Glomax Navigator luminometer. Dose–response analysis was performed using the R package "drc" (20 (link)). A four-parameter log-logistic model (LL.4) was fit to the viability data. For this log-logistic model, the Hill Coefficient, lower limit, and EC50 were allowed to vary but the upper limit was set to 1. Further details for this analysis can be found in the GitHub repository below.
+ Open protocol
+ Expand
5

Primary PBMC Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary PBMCs were isolated and incubated as described above for the SEB assay. After 3 days, when the culture supernatant was removed for IL-2 ELISA analysis, proliferation of the remaining cells in culture was assessed using the CellTiter 96 Aqueous One Solution Cell Proliferation Assay (MTS) (Promega) according to manufacturer’s instructions, and quantitated on a GloMax Navigator luminometer (Promega).
+ Open protocol
+ Expand
6

SARS-CoV-2 Antibody Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibodies were four-fold serially diluted and then incubated with SARS-CoV-2 pseudotyped HIV-1 reporter virus for 1 h at 37°C. The antibody/pseudotyped virus mixture was then added to HT1080/ACE2.cl14 cells. After 48 h, cells were washed with PBS, lysed with Luciferase Cell Culture Lysis reagent (Promega) and Nanoluc Luciferase activity in lysates was measured using the Nano-Glo Luciferase Assay System (Promega) and a Glomax Navigator luminometer (Promega). The relative luminescence units were normalized to those derived from cells infected with SARS-CoV-2 pseudotyped virus in the absence of monoclonal antibodies. The half-maximal inhibitory concentrations for monoclonal antibodies (IC50) were determined using four-parameter nonlinear regression (least-squares regression method without weighting) (GraphPad Prism).
+ Open protocol
+ Expand
7

Dual Luciferase Assay for US28 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293M cells were plated at 3x104 cells per well in 96-well, white-walled culture dishes. Cells were co-transfected with 50ng pcDNA3.1(-) control, or pcDNA3.1-US28-HA or US28-TurboID along with 10ng of pRL-SV40 (Rluc) and 50ng pGL4 firefly luciferase reporter vectors (SRE and SRF) using Fugene4K (Promega). At 18 hours post transfection growth medium was replaced with serum-free DMEM with or without small-molecule inhibitors at the indicated concentrations. Luciferase activity was measured in triplicate wells using the Dual Luciferase Reporter Assay System (Promega) at 6 hours post media replacement. Briefly, cell medium was removed and 20μL of passive lysis buffer was added to each well. The 96-well plate was placed at -20° C for 30 minutes followed by a 15-minute agitation at room temperature. Luciferase assay reagent was reconstituted and 50μL was injected per well in a Promega GloMax Navigator luminometer for luminescence detection. Assay results were transferred to an Excel spreadsheet, normalized to Renilla expression, set relative to the empty vector, and analyzed using GraphPad Prism 9.0 software.
+ Open protocol
+ Expand
8

Quantifying E. coli Viability via ATP

Check if the same lab product or an alternative is used in the 5 most similar protocols
A BacTiter-Glo Microbial Cell Viability assay was conducted according to manufacturer’s instructions (Promega; Madison, WI). E. coli was diluted to a starting absorbance of 0.01. BacTiter-Glo Reagent was added directly to the bacterial cells, supporting generation of a luminescent signal. Samples were transferred to 96 well white tissue culture plates and analyzed using a GloMax Navigator luminometer (Promega; Madison, WI). Each treatment, including the untreated control, was evaluated in sextuplicate (n = 6). Quantitation of cellular ATP, as indicated by luminescent signal, was proportional to the number of viable bacterial cells in each sample.
+ Open protocol
+ Expand
9

HIV-1 Env Pseudovirus Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutralization assays were conducted using TZM-bl cells as previously described (58 (link)). Briefly, patient plasma was tested in duplicate in 96-well plates using 1:20 dilution and serially diluted 3-fold seven times. Purified plasma IgG samples were tested using a primary concentration of 500 μg/ml and serially diluted 3-fold. HIV-1 Env pseudovirus was added to plasma or antibody serial dilutions and plates were incubated for 1 hour at 37° C. TZM-bl cells were then added at 1×104 cells per well with DEAE-Dextran at a final concentration of 11 μg/ml. After 48 hours of incubation at 37° C, plates were harvested using Promega Bright-Glo luciferase and luminescence detected using a Promega GloMax Navigator luminometer. Plasma dilutions that inhibited 50% or 80% of viral infection were determined (ID50 and ID80 titers, respectively). Neutralization assays were conducted in a laboratory meeting Good Clinical Laboratory Practice (GCLP) quality assurance criteria.
+ Open protocol
+ Expand
10

Luciferase Reporter Assay in AtT-20 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
AtT-20 cells were plated in 12-well dishes (4 × 105 cells per well) and transfections performed the next day using PEI 25K (Polysciences #23966–1) in triplicates. Transfected DNA (total 2 μg in 150 μl DMEM) was added to the PEI 25K solution (4 μl per 150 μl DMEM) and incubated at room temperature for 30 min before adding 100 μl of the mixture to each well. The media was changed 24 h after transfection and luciferase activity assessed 48 h after transfection. Growth medium was removed from transfected cells and 200 μl of lysis buffer (Tris 100 mM, NP40 0.5% and DTT 0.001 M) added to each well. After 10 min on a vigorous shaker, 100 μl of cell lysate supernatant was used for analysis using the GloMax Navigator luminometer (Promega) using the kinetics protocol (100 μl injection, speed 100 μl/s, integration time 10 s). Statistical significance was assessed by 2-way ANOVA and Tukey's multiple combinations test.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!